Skip to content

Wingspan M003WS0250150Recalls & reported problems

Stryker Corporation · Stent System · Class f · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04546540722775), received between Aug 31, 2016 and Sep 8, 2017 — classified as 2 injuries.

The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Activation, Positioning or Separation Problem1
  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Hemorrhage, Subarachnoid1
  • Infarction, Cerebral1
  • Neurological Deficit/Dysfunction1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjurySep 8, 2017Activation, Positioning or Separation Problem; Activation, Positioning or Separation Problem

    THE PATIENT UNDERWENT STENT ASSISTED BALLOON ANGIOPLASTY OF THE BASILAR TRUNK ARTERY STENOSIS WITH THE SUCCESSFUL IMPLANTATION OF THE FIRST STENT. IT WAS REPORTED THAT THE SECOND STENT (SUBJECT DEVICE) WAS NOT ABLE TO DEPLOY DUE TO ANATOMY. THE NEXT DAY OF THE PROCEDURE, TRACE AMOUNT OF SUBARACHNOID HEMORRHAGE WITHIN INTERPEDUNCULAR AND PREPONTINE CISTERN WAS OBSERVED. THE HEMORRHAGE WAS RESOLVED WITHOUT ANY RESIDUAL EFFECTS. NO TREATMENT WAS ADMINISTERED IN THE PHYSICIAN¿S OPINION, THE CAUSE OF THE HEMORRHAGE IS RELATED TO THE PROCEDURE; HOWEVER, RELATIONSHIP TO THE STENT AND THE BALLOON IS UNKNOWN.

    Patient problems: Hemorrhage, Subarachnoid

    MAUDE report 6853832 ↗
  • InjuryAug 31, 2016Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE PATIENT WITH A BASELINE OF A MODIFIED RANKIN SCALE (MRS) OF 3 UNDERWENT SUCCESSFUL STENT ASSISTED BALLOON ANGIOPLASTY OF THE 87 % STENOSED LEFT MIDDLE CEREBRAL ARTERY (L MCA). IT WAS REPORTED THAT POST PROCEDURE THE PATIENT EXPERIENCED A STROKE IN THE BASAL GANGLIA (TREATED AREA). THE PATIENT STROKE WAS ASSESSED AS A MRS OF 4 WITH A NATIONAL INSTITUTE OF HEALTH STROKE SCALE (NIHSS) OF 12. IT WAS REPORTED THAT MEDICAL THERAPY AND REHABILITATION HAVE BEEN PROVIDED AND IT IS STILL ONGOING. AT DISCHARGE THE PATIENT HAD RESIDUAL APHASIA AND RIGHT SIDED WEAKNESS. UPON DISCHARGE THE PATIENT WAS REPORTED TO HAVE A MRS OF 4 WITH A NIHSS OF 9. THE STUDY FACILITY INDICATED THAT THE RELATIONSHIP OF THE PROCEDURE TO THE STROKE WAS NOT RELATED; HOWEVER, TO THE DEVICE WAS UNKNOWN.

    Patient problems: Infarction, Cerebral; Neurological Deficit/Dysfunction

    MAUDE report 5919512 ↗

Other intracranial neurovascular stent devices

All intracranial neurovascular stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page